Shalini Dalal, MD

Peer-Reviewed Articles

1. Hui D, De La Rosa A, Wilson A, Nguyen T, Wu J, Delgado-Guay M, Azhar A, Arthur J, Epner D, Haider A, De La Cruz M, Heung Y, Tanco K, Dalal S, Reddy A, Williams J, Amin S, Armstrong TS, Breitbart W, Bruera E. Neuroleptic strategies for terminal agitation in patients with cancer and delirium at an acute palliative care unit: a single-centre, double-blind, parallel-group, randomised trial. Lancet Oncol 21(7):989-998, 2020. e-Pub 2020. PMID: 32479786.
2. Hui D, Abdelghani E, Chen J, Dibaj S, Zhukovsky D, Dev R, Tanco K, Haider A, Azhar A, Reddy A, Epner D, Arthur J, Dalal S, Heung Y, Reddy S, De La Cruz M, Liu D, Bruera E. Chronic Non-Malignant Pain in Patients with Cancer Seen at a Timely Outpatient Palliative Care Clinic. Cancers (Basel) 12(1), 2020. e-Pub 2020. PMID: 31952220.
3. Haider A, Azhar A, Nguyen K, Dev R, Naqvi SMA, Naqvi SMA, Edwards T, Reddy A, Dalal S, Tanco KC, Arthur J, Williams JL, Park M, Liu DD, Dibaj SS, Bruera E. Concurrent use of opioids with benzodiazepines or nonbenzodiazepine sedatives among patients with cancer referred to an outpatient palliative care clinic. Cancer 125(24):4525-4531, 2019. e-Pub 2019. PMID: 31460669.
4. Dev R, Del Fabbro E, Dalal S. Endocrinopathies and cancer cachexia. Curr Opin Support Palliat Care 13(4):286-291, 2019. e-Pub 2019. PMID: 31567482.
5. Hui D, Hernandez F, Larsson L, Liu D, Kilgore K, Naberhuis J, Virgilio A, Reddy S, Reddy A, Dalal S, Haider A, Driver L, Azhar A, Dev R, Bruera E. Prophylactic Fentanyl Sublingual Spray for Episodic Exertional Dyspnea in Cancer Patients: A Pilot Double-Blind Randomized Controlled Trial. J Pain Symptom Manage 58(4):605-613, 2019. e-Pub 2019. PMID: 31276809.
6. Haider A, Qian Y, Lu Z, Naqvi S, Zhuang A, Reddy A, Dalal S, Arthur J, Tanco K, Dev R, Williams J, Wu J, Liu D, Bruera E. Implications of the Parenteral Opioid Shortage for Prescription Patterns and Pain Control Among Hospitalized Patients With Cancer Referred to Palliative Care. JAMA Oncol 5(6):841-846, 2019. e-Pub 2019. PMID: 30896771.
7. Arthur J, Tanco K, Park M, Haider A, Maligi C, Dalal S, Naqvi SMA, Liu D, Bruera E. Personalized Pain Goal as an Outcome Measure in Routine Cancer Pain Assessment. J Pain Symptom Manage 56(1):80-87, 2018. e-Pub 2018. PMID: 29526610.
8. Hui D, Hess K, Dibaj SS, Arthur J, Dev R, Dalal S, Reddy S, Bruera E. The minimal clinically important difference of the Richmond Agitation-Sedation Scale in patients with cancer with agitated delirium. Cancer 124(10):2246-2252, 2018. e-Pub 2018. PMID: 29469951.
9. Dalal S, Moore JA, Colleen M. Gallagher. We Didn't Consent to This. Narrative Inquiry in Bioethics 7(2):171-178, 2017. PMID: 29056648.
10. Dans M, Smith T, Back A, Baker JN, Bauman JR, Beck AC, Block S, Campbell T, Case AA, Dalal S, Edwards H, Fitch TR, Kapo J, Kutner JS, Kvale E, Miller C, Misra S, Mitchell W, Portman DG, Spiegel D, Sutton L, Szmuilowicz E, Temel J, Tickoo R, Urba SG, Weinstein E, Zachariah F, Bergman MA, Scavone JL. NCCN Guidelines Insights: Palliative Care, Version 2.2017. J Natl Compr Canc Netw 15(8):989-997, 2017. PMID: 28784860.
11. Dalal S, Bruera E. End of Life Care Matters: Palliative Cancer Care Results in Better Care and Lower Costs. Oncologist 22(4):361-368, 2017. e-Pub 2017. PMID: 28314840.
12. Dalal S, Bruera S, Hui D, Yennu S, Dev R, Williams J, Masoni C, Ihenacho I, Obasi E, Bruera E. Use of Palliative Care Services in a Tertiary Cancer Center. Oncologist 21(1):110-8, 2016. e-Pub 2015. PMID: 26614711.
13. Levy M, Smith T, Alvarez-Perez A, Back A, Baker JN, Beck AC, Block S, Dalal S, Dans M, Fitch TR, Kapo J, Kutner JS, Kvale E, Misra S, Mitchell W, Portman DG, Sauer TM, Spiegel D, Sutton L, Szmuilowicz E, Taylor RM, Temel J, Tickoo R, Urba SG, Weinstein E, Zachariah F, Bergman MA, Scavone JL. Palliative Care Version 1.2016. J Natl Compr Canc Netw 14(1):82-113, 2016. PMID: 26733557.
14. Dalal S, Hui D, Dev R, Yeung S, Sobti N, de la Cruz M, Vidal M, Bedi D, Bruera E, Litton J. Prognostic Role of Skeletal Muscle Mass and Fat Distribution on Clinical Outcomes in Post-menopausal Women with Operable Stage Breast Cancer. Journal of Cachexia, Sarcopenia and Muscle, 2015.
15. Hui D, Park M, Liu D, Reddy A, Dalal S, Bruera E. Attitudes and Beliefs Toward Supportive and Palliative Care Referral Among Hematologic and Solid Tumor Oncology Specialists. Oncologist 20(11):1326-32, 2015. e-Pub 2015. PMID: 26417037.
16. Hui D, dos Santos R, Reddy S, Nascimento MS, Zhukovsky DS, Paiva CE, Dalal S, Costa ED, Walker P, Scapulatempo HH, Dev R, Crovador CS, De La Cruz M, Bruera E. Acute symptomatic complications among patients with advanced cancer admitted to acute palliative care units: A prospective observational study. Palliat Med 29(9):826-33, 2015. e-Pub 2015. PMID: 25881622.
17. Naing A, Dalal S, Abdelrahim M, Wheler J, Hess K, Fu S, Hong DS, Janku F, Falchook GS, Ilustre A, Ouyang F, Kurzrock R.. Olanzapine for cachexia in patients with advanced cancer: an exploratory study of effects on weight and metabolic cytokines. Support Care Cancer 23(9), 2015. e-Pub 2015. PMID: 25680763.
18. Dev R, Hui D, Del Fabbro E, Delgado-Guay MO, Sobti N, Dalal S, Bruera E.. Association between hypogonadism, symptom burden, and survival in male patients with advanced cancer. Cancer 120(10), 2015. e-Pub 2014. PMID: 24577665.
19. Dev R, Hui D, Chisholm G, Delgado-Guay M, Dalal S, Del Fabbro E, Bruera E. Hypermetabolism and symptom burden in advanced cancer patients evaluated in a cachexia clinic. J Cachexia Sarcopenia Muscle 6(1):95-8, 2015. e-Pub 2015. PMID: 26136416.
20. Wu W, Liu X, Chaftari P, Cruz Carreras MT, Gonzalez C, Viets-Upchurch J, Merriman K, Tu SM, Dalal S, Yeung SC. Association of body composition with outcome of docetaxel chemotherapy in metastatic prostate cancer: a retrospective review. PLoS One 10(3):e0122047, 2015. e-Pub 2015. PMID: 25822612.
21. Reddy A, Yennurajalingam S, Desai H, Reddy S, de la Cruz M, Wu J, Liu D, Rodriguez EM, Waletich J, Shin SH, Gayle V, Patel P, Dalal S, Vidal M, Tanco K, Arthur J, Tallie K, Williams J, Silvestre J, Bruera E. The opioid rotation ratio of hydrocodone to strong opioids in cancer patients. Oncologist 19(11):1186-93, 2014. e-Pub 2014. PMID: 25342316.
22. Levy MH, Smith T, Alvarez-Perez A, Back A, Baker JN, Block S, Codada SN, Dalal S, Dans M, Kutner JS, Kvale E, Misra S, Mitchell W, Sauer TM, Spiegel D, Sutton L, Taylor RM, Temel J, Tickoo R, Urba SG, Van Zyl C, Weinstein SM, Bergman MA, Scavone JL. Palliative care, version 1.2014. J Natl Compr Canc Netw 12(10):1379-88, 2014. PMID: 25313178.
23. Dev R, Hui D, Del Fabbro E, Delgado-Guay MO, Sobti N, Dalal S, Bruera E. Association between hypogonadism, symptom burden, and survival in male patients with advanced cancer. Cancer 120(10):1586-93, 2014. e-Pub 2014. PMID: 24577665.
24. Rhondali W, Burt S, Wittenberg-Lyles E, Bruera E, Dalal S. Medical oncologists' perception of palliative care programs and the impact of name change to supportive care on communication with patients during the referral process. A qualitative study. Palliat Support Care 11(5):1-8, 2013. e-Pub 2013. PMID: 23302500.
25. Dalal S, Tanco KC, Bruera E. State of art of managing pain in patients with cancer. Cancer J 19(5):379-89, 2013. PMID: 24051610.
26. Yennurajalingam S, Frisbee-Hume S, Palmer JL, Delgado-Guay MO, Bull J, Phan AT, Tannir NM, Litton JK, Reddy A, Hui D, Dalal S, Massie L, Reddy SK, Bruera E. Reduction of cancer-related fatigue with dexamethasone: a double-blind, randomized, placebo-controlled trial in patients with advanced cancer. J Clin Oncol 31(25):3076-82, 2013. e-Pub 2013. PMID: 23897970.
27. Rhondali W, Perez-Cruz P, Hui D, Chisholm GB, Dalal S, Baile W, Chittenden E, Bruera E. Patient-physician communication about code status preferences: A randomized controlled trial. Cancer 119(11):2067-73, 2013. e-Pub 2013. PMID: 23564395.
28. S Dalal, E Bruera. Access to Opioid Analgesics and Pain Relief for Patients With Cancer. Nature Reviews Clinical Oncology 10(2):108-116, 2013.
29. Bruera E, Hui D, Dalal S, Torres-Vigil I, Trumble J, Roosth J, Krauter S, Strickland C, Unger K, Palmer JL, Allo J, Frisbee-Hume S, Tarleton K. Parenteral hydration in patients with advanced cancer: a multicenter, double-blind, placebo-controlled randomized trial. J Clin Oncol 31(1):111-8, 2013. e-Pub 2012. PMID: 23169523.
30. Levy MH, Adolph MD, Back A, Block S, Codada SN, Dalal S, Deshields TL, Dexter E, Dy SM, Knight SJ, Misra S, Ritchie CS, Sauer TM, Smith T, Spiegel D, Sutton L, Taylor RM, Temel J, Thomas J, Tickoo R, Urba SG, Von Roenn JH, Weems JL, Weinstein SM, Freedman-Cass DA, Bergman MA, NCCN (National Comprehensive Cancer Network). Palliative care. J Natl Compr Canc Netw 10(10):1284-309, 2012. PMID: 23054879.
31. Dev R, Dalal S, Bruera E. Is there a role for parenteral nutrition or hydration at the end of life?. Curr Opin Support Palliat Care 6(3):365-370, 2012. PMID: 22801468.
32. Hui D, Arthur J, Dalal S, Bruera E. Quality of the supportive and palliative oncology literature: a focused analysis on randomized controlled trials. Support Care Cancer 20(8):1779-1785, 2012. e-Pub 2011. PMID: 21935717.
33. Dalal S, Hui D, Nguyen L, Chacko R, Scott C, Roberts L, Bruera E. Achievement of personalized pain goal in cancer patients referred to a supportive care clinic at a comprehensive cancer center. Cancer 118(15):3869-77, 2012. e-Pub 2011. PMID: 22180337.
34. Dalal S, Hui D, Bidaut L, Lem K, Del Fabbro E, Crane C, Reyes-Gibby CC, Bedi D, Bruera E. Relationships among body mass index, longitudinal body composition alterations, and survival in patients with locally advanced pancreatic cancer receiving chemoradiation: a pilot study. J Pain Symptom Manage 44(2):181-91, 2012. e-Pub 2012. PMID: 22695045.
35. Hui D, Kilgore K, Fellman B, Urbauer D, Hall S, etal.. Development and Cross-Validation of the In-Hospital Mortality Prediction in Advanced Cancer Patients Score: A Preliminary Study. Journal of Palliative Medicine 15(8):902-09, 2012.
36. Hui D, Kilgore K, Nguyen L, Hall S, Fajardo J, Cox-Miller TP, Palla SL, Rhondali W, Kang JH, Kim SH, Del Fabbro E, Zhukovsky DS, Reddy S, Elsayem A, Dalal S, Dev R, Walker P, Yennu S, Reddy A, Bruera E. The Accuracy of Probabilistic Versus Temporal Clinician Prediction of Survival for Patients with Advanced Cancer: A Preliminary Report. Oncologist, 2011. e-Pub 2011. PMID: 21976316.
37. Del Fabbro E, Nooruddin Z, Hui D, Dalal S, Bruera E. Nutrition Impact Symptoms in Cancer Patients Referred to a Cachexia Clinic at a Comprehensive Cancer Center. J Palliat Med 14(9):1004-1008, 2011. PMID: 21793729.
38. Del Fabbro E, Hui D, Dalal S, Dev R, Noorhuddin Z, Bruera E. Clinical Outcomes and Contributors to Weight Loss in a Cancer Cachexia Clinic. J Palliat Med 14(9):1004-8, 2011. e-Pub 2011. PMID: 21793729.
39. Dev R, Hui D, Dalal S, Nooruddin ZI, Yennurajalingam S, Del Fabbro E, Bruera E. Association between serum cortisol and testosterone levels, opioid therapy, and symptom distress in patients with advanced cancer. J Pain Symptom Manage 41(4):788-95, 2011. e-Pub 2011. PMID: 21276699.
40. Dalal S, Palla S, Hui D, Nguyen L, Chacko R, Li Z, Fadul N, Scott C, Thornton V, Coldman B, Amin Y, Bruera E. Association Between a Name Change from Palliative to Supportive Care and the Timing of Patient Referrals at a Comprehensive Cancer Center. Oncologist 16(1):105-111, 2011. e-Pub 2011. PMID: 21212438.
41. Del Fabbro E, Dev R, Hui D, Dalal S, Bruera E. Secondary Cachexia in Patients with Advanced Cancer. J Pain Symptom Manage 41(1):233-234, 2011.
42. Del Fabbro E, Hui D, Nooruddin Z, Dalal S, Dev R, Freer G, Palmer JL, Bruera E. Association between hypogonadism, inflammatory marker, symptom survival in cancer patients with cachexia: A preliminary report. Cancer, 2010.
43. Del Fabbro E, Hui D, Nooruddin ZI, Dalal S, Dev R, Freer G, Roberts L, Palmer JL, Bruera E. Associations Among Hypogonadism, C-Reactive Protein, Symptom Burden, and Survival in Male Cancer Patients with Cachexia: A Preliminary Report. J Pain Symptom Manage 39(6):1016-1024, 2010. PMID: 20457506.
44. Mori M, Fadul NA, Bruera E, Dalal S. Hypocalcemia Associated with Strontium-89 Administration in a Patient with Diffuse Bone Metastases from Neuroendocrine Carcinoma. J Pain Symptom Manage 37(5):923-929, 2009. PMID: 19041217.
45. Dalal S, Del Fabbro E, Bruera E. Is there a role for hydration at the end of life?. Curr Opin Support Palliat Care 3(1):72-78, 2009. PMID: 19365165.
46. Fadul NA, El Osta B, Dalal S, Poulter VA, Bruera E. Comparison of Symptom Burden among Patients Referred to Palliative Care with Hematologic Malignancies versus those with Solid Tumors. J Palliat Med 11(3):422-7, 2008. PMID: 18363482.
47. Dalal S, Zhukovsky DS. Pathophysiology and management of hot flashes. J Support Oncol 4(7):315-20, 325, 2006. PMID: 16892692.
48. Dalal S, Del Fabbro E, Bruera E. Symptom control in palliative care-part I: oncology as a paradigmatic example. J Palliat Med 9(2):391-408, 2006. PMID: 16629570.
49. Del Fabbro E, Dalal S, Bruera E. Symptom Control in Palliative Care-Part III: Dyspnea and Delirium. J Palliat Med 9(2):422-36, 2006. PMID: 16629572.
50. Del Fabbro E, Dalal S, Bruera E. Symptom Control in Palliative Care-Part II: Cachexia/Anorexia and Fatigue. J Palliat Med 9(2):409-21, 2006. PMID: 16629571.
51. Dalal S, Zhukovsky DS. Pathophysiology and management of fever. J Support Oncol 4(1):9-16, 2006. PMID: 16444847.
52. Dalal S, Bruera E. Dehydration in cancer patients: to treat or not to treat. J Support Oncol 2(6):467-79, 483, 2004. PMID: 15605914.
53. Dalal S. Lipid Metabolism in Cancer Cachexia. Ann Palliative Med 2018. PMID: 30525767.
54. Dalal S. Intravenous Naloxone Utilization among hospitalized cancer patients on Opioids at a Tertiary Cancer Center. MASCC/ISOO 2018 Annual Meeting.
55. Dalal, S. The impact of race/ethnicity on the prognostic associations between general and visceral obesity and breast cancer outcomes. Society on Sarcopenia, Cachexia and Wasting Disorders (SCWD).

Invited Articles

1. Dalal S, Bruera E. Pain Management for Patients With Advanced Cancer in the Opioid Epidemic Era. Am Soc Clin Oncol Educ Book 39:24-35, 2019. e-Pub 2019. PMID: 31099619.
2. Dalal S, Bruera E. Assessing cancer pain. Curr Pain Headache Rep 16(4):314-24, 2012. PMID: 22585314.
3. Dalal S. Book Review: Ensuring Delivery of the Highest Quality of Care for Dying Patients. J Pain Symptom Manage 42(6):967-968, 2011.
4. Dalal S, Bruera E. Assessment and management of pain in the terminally ill. Prim Care Clinic Office Pract 38(2):195-223, 2011. PMID: 21628035.
5. Dalal S, Bruera E. Global Perspectives in Cancer Pain--progress and ongoing issues in the United States. Pain Res Manag 14(5):363-364, 2009. PMID: 19946974.

Manuals, Teaching Aids, Other Teaching Publications

1. Dalal S. Cachexia: M.D. Anderson's Guide to Palliative Care for Nurses: Houston, 2006.
2. Dalal S. Fatigue: M.D. Anderson's Guide to Palliative Care for Nurses: Houston, 2006.

Other Articles

1. Dalal S, Bruera E UpToDate: Palliative care: Overview of pruritus and sweating.

Abstracts

1. Dalal S, Pimentel LE, Wygant C. Multidimensional Assessment Of Cancer Pain. Moving Beyond The Basics. 2013 American Academy of Hospice and Palliative Medicine & Hospice and Palliative Nurses Association Annual Assembly, 2013.
2. Dalal S, Hui D, Nguyen LMT, Chacko R, Bruera E. Achievement of personalized pain goal (PPG) in cancer patients referred to a supportive-care clinic. Journal of Clinical Oncology 29(9060), 2012.
3. Dalal S, Hui D, Nguyen L, Chacko R, Bruera E. Assessment of personalized pain goal (PPG) in cancer patients referred to the Supportive Care Clinic for pain management. 7th World Research Congress of the European Association for Palliative Care, 2012.
4. Dalal S, Hui D, Ngyuen L, Chacko R, Bruera. Achievement of personalized pain goal (PPG) in cancer patients referred to the supportive care clinic at a comprehensive cancer center. Proceedings of Multinational Association of Supportive Care in Cancer (MASCC), Annual Meeting. Journal of Supportive Care in Cancer 19(Suppl 2), 2011.
5. Hui D, Kilgore K, Nguyen L, Hall S, Fajardo J, Cox-Miller T, Rhondali W, Kim SH, Kang, JH, Palla S, Del Fabbro E, Zhukovsky DS, Reddy S. Elsayem A, Dalal S, Walker P, Dev R, Yennu S, Reddy A, Bruera E. The accuracy of clinical prediction of survival (CPS) for advanced cancer patients: The role of profession and probability questionProceedings of Multinational Association of Supportive Care in Cancer (MASCC), Annual Meeting. Journal of Supportive Care in Cancer 19(Suppl 2), 2011.
6. Dev R, Del Fabbro E, Palla S, Hui D, Guitierrez N, Dalal S, Yennurajalingam S. Bruera E. Vitamin D Deficiency and Endogrin Abnormalities in Advanced Cancer Patients Proceedings of Multinational Association of Supportive Care in Cancer (MASCC), Annual Meeting. Journal of Supportive Care in Cancer 19(Suppl 2), 2011.
7. Hui D, Kilgore KL, Nguyen LMT, Hall S, Fajardo J, Cox-Miller T, Urbauer D. Fellman B, Rhondali W, Kang JH, Kim H, Del Fabbro E, Zhukovsky DS, Reddy SK, Elsayem AF, Dalal S, Walker P, Dev R, Yennurajalingam S, Bruera E. Predictors of in-hospital mortality in advanced cancer patients submitted to an acute palliative care unit (APCU): A prospective study Proceedings of Multinational Association of Supportive Care in Cancer (MASCC), Annual Meeting. Support Care Cancer 19(Supplement 2):S221, 2011. PMID: 21656340.
8. Dalal S, Hui D, Nguyen LMT, Chacko R and Bruera E. Achievement of personalized pain goal (PPG) in cancer patients referred to a supportive care clinic. Proceedings of American Association of Clinical Oncology, Annual Meeting. Journal of Clinical Oncology 29(15S), 2011.
9. Dalal S, Palla SL, Chacko R, Nguyen L, Fadul N, Li Z, Bruera E. Impact of change in service name from "Palliative" to "Supportive" care on patient referral at a comprehensive cancer center. Proceedings of American Society of Clinical Oncology (ASC0), Annual Meeting. Journal of Clinical Oncology 28(15S), 2010.
10. Dalal S, Palla S, Chacko R, Nguyen L, Fadul N, Bruera E. Does A Name Change from "Palliative" to "Supportive" Care Have Any Impact on Patient Referrals? A Retrospective Data Review. Proceedings of Multinational Association of Supportive Care in Cancer (MASCC), Annual Meeting. Journal of Supportive Care in Cancer 18(Supplement 3):S67-S220, 2010.
11. Del Fabbro D, Dalal S, Bruera E.. A randomized placebo-controlled trial of melatonin for poor appetite in advanced cancer patients. Proceedings of American Association of Clinical Oncology, Annual Meeting. Journal of Clinical Oncology 28(15S), 2010.
12. Nooruddin Z, Hui D, Dalal S, Bruera E, Del Fabbro E. Findings and Interventions in Cancer Patients referred to a Cachexia Clinic. Proceedings of Multinational Association in Supportive Care (MASCC), Annual Meeting. Journal of Supportive Care in Cancer 17, 2009.
13. Dalal S, Hui D, Noorruddin Z, Del Fabbro E, Freer G, Bruera E. Impact of a Multidisciplinary Cachexia Clinic at a Tertiary Cancer Hospital on Patient Related Outcomes. Proceedings of Multinational Association in Supportive Care (MASCC), Annual Meeting. Journal of Supportive Care in Cancer 17, 2009.
14. Del Fabbro E, Hui D, Nooruddin ZR, Dalal S, Dev R, Freer G, Palmer L, Bruera E. Association between inflammatory markers, symptom burden, hypogonadism and survival in cancer patients with cachexia. Proceedings of American Society Clinical Oncology (ASCO), Annual Meeting. Journal of Clinical Oncology 27(15S), 2009.
15. Del Fabbro E, Hui D, Nooruddin Z, Dalal S, Palmer L, Bruera E. Association Between Inflammatory Markers, Symptom Burden, Hypogonadism and Survival In Cancer Patients with Cachexia. Proceedings of Multinational Association of Supportive Care in Cancer (MASCC), Annual Meeting. Journal of Supportive Care in Cancer 17:857-1039, 2009.
16. Dalal S, Hui D, Bidaut L, Del Fabbro E, Reyes-Gibby C, Deepak B, Lem K, Hess K, Crane C, Bruera E. Differential Impact of Changes in Muscle and Adipose Tissue on Survival of Men and Women with Locally Advanced Pancreatic Cancer (LAPC) receiving Chemoradiation (CRT). Proceedings of American Society Clinical Oncology (ASCO), Annual Meeting. Journal of Clinical Oncology 26(May 20 suppl), 2008.
17. Dalal S, Hui D, Bidaut L, Hess K, Crane C, Bruera E. Gender based differences in the relationship between body composition alterations, as measured by computerized tomography (CT) imaging, and survival, in locally advanced pancreatic cancer (LAPC) receiving chemoradiation. Proceedings of Multinational Association of Supportive Care in Cancer (MASCC), Annual Meeting. Journal of Supportive Care in Cancer 16, 2008.
18. Dalal S, Del Fabbro E, Freer G, Bruera E. Relationship between inflammation and symptom distress in cachectic cancer patients assessed at a cachexia clinic in a comprehensive cancer center. Proceedings of Multinational Association in Supportive Care (MASCC), Annual Meeting. Journal of Supportive Care in Cancer 16, 2008.
19. Braiteh F, Dalal S, Khuwaja A, David H, Bruera E, Kuzrock R. Phase I pilot study of the safety and tolerability of olanzapine (OZA) for the treatment of cachexia in patients with advanced cancer. Proceedings of American Society Clinical Oncology (ASCO), Annual Meeting. Journal of Clinical Oncology 26(I5S), 2008.
20. Del Fabbro E, Dalal S, Delgado M, Freer G, Bruera E. Secondary vs. primary cachexia in patients with advanced cancer. Proceedings of American Society Clinical Oncology (ASCO) Annual Meeting. Journal of Clinical Oncology. Journal of Clinical Oncology 25(18S), 2007.
21. Dalal S, Del Fabbro E, Yennurajalingam S, Palmer S, Bruera E. Cachexia syndrome symptom cluster in patients referred to a specialized cachexia clinic in a comprehensive cancer center. Proceedings of Multinational Association in Supportive Care (MASCC), Annual Meeting. Journal of Supportive Care in Cancer 15:774-775, 2007.
22. Fadul N, El Osta B, Dalal S, Elsayem A and Bruera E. Symptom burden severity in patients with advanced solid vs. hematological malignancies. Proceedings of Multinational Association in Supportive Care (MASCC), Annual Meeting. Journal of Supportive Care in Cancer 15, 2007.
23. Reddy S, Dalal S, Swafford J, El Osta B, Pei B, Palmer J, Bruera E. The effect of methadone on the QTc interval in advanced cancer patients. Proceedings of American Society Clinical Oncology (ASCO), Annual Meeting. Journal of Clinical Oncology 25(18S), 2007.

Book Chapters

1. Dalal S. UTI. In: Internal Medicine Issues in Palliative Care. Oxford University Press, 2014.
2. Dalal S. Pneumonia. In: Internal Medicine Issues in Palliative Care, 2014.
3. Dalal S, Bruera E. Methadone and Buprenorphine Prescribing in the Palliative Care Population. In: Handbook of Methadone Prescribing and Buprenorphine Therapy. Springer: New York, 241-261, 2013.
4. Dalal S, Bruera E. Principles of Hospice and Palliative Care. In: Oncology for the Primary Care Clinician. Lippincott Williams & Wilkins: Philadelphia, 2013.
5. Dalal S. Chapter 7: Dehydration in Cancer Patients. In: Oxford American Handbook of Hospice and Palliative Medicine. 1. Oxford University Press: New York, 97-103, 2011.
6. Dalal S. Chapter 10: Chronic Nausea and Vomiting. In: Oxford American Handbook of Hospice and Palliative Medicine. 1. Oxford University Press: New York, 127-138, 2011.
7. Dalal S, Bruera E.. Chapter 15: Cancer Anorexia and Cachexia. In: Supportive Oncology, 1st Edition. 1st. Elsevier Saunders: Philadelphia, 151-160, 2011.
8. Dalal S. Nutritional Management in Recurrent, Advanced or Metastatic Cancer. In: Nutrition and the Cancer Patient. 1st. Oxford University Press: New York, 435-444, 2010.
9. Dalal S, Palat G, Bruera E. Chronic Nausea and Vomiting. In: Principles and Practice of Palliative Care and Supporting Oncology. 3rd. Lippincott Williams & Wilkins: Philadelphia PA, 151-162, 2007.
10. Dalal S, Palat G, Bruera E. Management of Dyspnea. In: Principles and Practice of Palliative Care and Supportive Oncology. 3rd. Lippincott Williams & Wilkins: Philadelaphia, PA, 277-290, 2007.
11. Dalal S, Zhukovsky DS, Bruera E. Fever and Hot Flashes. In: Palliative Medicine. Edward Arnold Ltd: London, 2006.
12. Dalal S, Bruera E. Pathophysiology of chemotherapy induced nausea and emesis: In Chemotherapy Induced Nausea and Emesis. In: Prevention of Chemotherapy Induced Nausea and Vomiting. CMP Healthcare Media: New York, 2004.